AB-001
≈ 2 min read
Names in other languages
- EnglishAB-001
- 日本語AB-001
- shAB-001
- СрпскиAB-001
- 中文AB-001
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
AB-001 (1-pentyl-3-(1-adamantoyl)indole) is a designer drug that was found as an ingredient in synthetic cannabis smoking blends in Ireland in 2010 and Hungary and Germany in 2011. It is unclear who AB-001 was originally developed by, but it is structurally related to compounds such as AM-1248 and its corresponding 1-(tetrahydropyran-4-ylmethyl) analogue, which are known to be potent cannabinoid agonists with moderate to a high selectivity for CB 2 over CB 1 . The first published synthesis and pharmacological evaluation of AB-001 revealed that it acts as a full agonist at CB1 (EC 50 = 35 nM) and CB2 receptors (EC 50 = 48 nM). However, AB-001 was found to possess only weak cannabimimetic effects in rats at doses up to 30 mg/kg, making it less potent than the carboxamide analogue APICA, which possesses potent cannabimimetic activity at doses of 3 mg/kg.
AB-001 (1-pentyl-3-(1-adamantoyl)indole) is a designer drug that was found as an ingredient in synthetic cannabis smoking blends in Ireland in 2010 and Hungary and Germany in 2011. It is unclear who AB-001 was originally developed by, but it is structurally related to compounds such as AM-1248 and its corresponding 1-(tetrahydropyran-4-ylmethyl) analogue, which are known to be potent cannabinoid agonists with moderate to a high selectivity for CB 2 over CB 1 . The first published synthesis and pharmacological evaluation of AB-001 revealed that it acts as a full agonist at CB1 (EC 50 = 35 nM) and CB2 receptors (EC 50 = 48 nM). However, AB-001 was found to possess only weak cannabimimetic effects in rats at doses up to 30 mg/kg, making it less potent than the carboxamide analogue APICA, which possesses potent cannabimimetic activity at doses of 3 mg/kg.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1369197596 under CC BY-SA 4.0; modifications have been made.